Study Identifies Key Genes and Potential Therapies in Myasthenia Gravis via Lipid Metabolism Regulation
The study identified IRS2 and ALDH2 as key genes linked to lipid metabolism dysregulation in myasthenia gravis, with potential therapeutic candidates including metformin and cyclophosphamide.